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ABSTRACT 
IRON AQUISITION IN THE DENTAL PATHOGEN AGGERGATIBACTER 
ACTINOMYCETEMCOMITANS 
By 
Porscha LaRai Jefferson 
July 25, 2012 
The dental pathogen A. actinomycetemcomitans, a Gram- negative organism, has 
been associated with aggressive forms of periodontitis. A. actinomycetemcomitans 
requires iron to grow. In the host, iron-binding proteins such as transferrin, lactoferrin, 
hemoglobin, and ferritin, maintain a low free-iron concentration. Microorganisms, 
however, have evolved complex systems to efficiently harvest iron. 
Th iron acquisition systems encoded in the genome of A. actinomycetemcomitans 
are likely tailored towards the specific survival strategies needed to survive in the oral 
biofilm. The objectives of this project were to determine the growth of A. 
actinomycetemcomitans in different iron sources and to examine the expression of the 
various iron uptake systems encoded by this organism under these conditions. 
A. actinomycetemcomtians was grown in chemically defined media (CDM) with 
or without an iron chelator (dipyridyl (DIP), and supplemented with various iron forms to 
determine growth. 
VI 
The growth of A. actinomycetemcomitans was decreased in a dose-dependent 
manner when cultured in CDM without exogenous ferrous sulfate supplemented with 
DIP (CDIDIP). Growth of A. actinomycetemcomitans was restored most efficiently when 
CDMIDIP was supplemented with hemin, less so with ferric citrate, and ferric chloride, 
and not with ferrous sulfate. Using these growth conditions,. we examined the differential 
regulation of the numerous iron uptake systems encoded III the A. 
actinomycetemcomitans genome. 
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Periodontal disease is a chronic progressive disease that affects various structures 
of the periodontal tissues including the alveolar bone and periodontal ligament. 
Periodontal disease has been divided into two separate categories: Gingivitis and 
Periodontitis. Both diseases are inflammatory conditions that are encompassed in the 
term periodontal disease, however the affects of both diseases are quite different. 
Gingivitis, the initial stage of periodontal disease, is an inflammation of the gingival 
tissue characterized by swelling, redness, and bleeding upon probing of the gingiva (3). 
Although gingivitis is reversible following proper oral hygiene, if left untreated, it can 
progress into the more severe, chronic inflammatory condition, periodontitis. 
Periodontitis always develops from gingivitis however not all gingivitis will progress into 
periodontitis. 
Periodontitis is defined as a condition in which there is an inflammatory 
reaction that occurs in the periodontium resulting in the destruction of the supporting soft 
tissues surrounding the teeth, loss of gingivial fibers of the periodontal ligament, and 
resorption of the alveolar bone. Periodontitis has also been further categorized into mild, 
moderate, and severe periodontitis based on the patients clinical attachement loss (39,40). 
Mild periodontits presents with 1-2 mm of attachment loss, moderate periodontitis 
presents with 3-4 mm of attachment loss, and severe periodontitis displays attachment 
loss greater than 4 mm. Periodontitis is even further divided into chronic or acute forms 
and generalized (presenting in greater than 30% of the oral cavity) or localized (less than 
30% of the oral cavity is involved). 
Due to the progressive nature of this condition, if periodontitis is left untreated, 
loosening and/or tooth loss is usually the result. Due to the destructive nature of 
periodontal disease, it has been a frequent interest in many research projects. It has been 
concluded that periodontal disease is the clinical result of a complex interaction between 
the host and plaque bacteria. Destruction of periodontal supporting tissues happens as a 
response to very intricate host-parasite interactions. The net result of this host-parasite 
interaction, which in an unpredictable moment, accumulate and exceed the threshold of 
tissue integrity thus causing tissue destruction and ultimate bone loss. 
Periodontal disease is the most prevalent of bone diseases in humans and has long 
been implicated as a risk factor in impairment of oral functions and tooth loss. 10-15% of 
adults that have periodontal disease have it severely enough that it results in tooth loss, 
ultimately leading to mastication malfunction and ageusia. While periodontal disease is 
prevalent worldwide, it has had a significant impact on the United States population (9, 
18, 52). Brown et al estimate that about 21.8% of adults (22.6 million) exhibit signs of 
mild periodontitis, 9.5% (9.9 million) display signs of moderate periodontitis, and about 
3.1 % (about 3.2 million) exhibit signs of advanced periodontitis (9). The total amount 
expended for periodontal preventive procedures as well as the treatment of periodontal 
diseases in the U.S. was $14.3 billion in 1999 (9). Undoubtedly, innovative methods for 
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the prevention and treatment of periodontal disease would have a major impact on 
healthcare costs. 
Past research has suggested periodontal disease can be complicated by certain 
systemic diseases, however more recently, studies suggest that the reverse may also be 
true (13, 28, 29, 32, 44, 46, 50) . Current research, however controversial, proposes that 
periodontal disease has important systemic implications, and can influence other diseases 
such as cardiovascular disease (28, 29, 36, 39), pulmonary disease (44, 55) diabetes (23, 
32, 50), and adverse pregnancy outcomes (11, 46, 47). Thus, a better understanding of the 
factors that contribute to periodontal disease can be used to develop measures to improve 
not only oral health of the patient, but also overall health of individuals. 
The onset and progression of periodontal disease is associated with several risk 
factors, including but not limited to gender, age, socio-economic status, nutrition, stress, 
genetic makeup, and tobacco smoke. Though there are several risk factors, tobacco 
smoke has been considered one of the most important risk factors associated with 
periodontal disease (54). It is theorized that there is a positive correlation between 
increased tobacco usage in the population and increased numbers of periodontal 
infections (33, 52). A dose-dependent correlation has been demonstrated between the 
frequency of an individual smoker and the severity of the deteriorating periodontal health 
of that individual (6). Smokers are extremely more susceptible to periodontitis, with 
increased alveolar bone resorption (24), attachment loss, percentage of oral sites with 
significant attachment loss (25), tooth mobility, and tooth loss (42) than non smokers. 
Additionally, patients who smoke are more often refractory to treatment than non-
smokers (49). Despite conflicting data that tobacco smoke may not influence the sub-
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gingival microflora (22, to), recent data strongly indicates that tobacco-induced 
susceptibility to periodontitis is correlated with populational shifts in the microbial 
composition of the oral biofilm (15, 19,26). For example, Umeda et al showed that there 
is an increased risk of Treponema denticola inhabiting the oral cavity of smokers (61); 
while Zambon et al reported a higher prevalence of Aggregatibacter 
actinomycetemcomitans, Tannerella forsythia and Porphyromonas gingivalis in smokers 
(66). 
While all of these factors playa role in the progression and severity of the disease, 
there is clear evidence that the inflammatory response in the periodontum is initiated 
against the resident microbial biofilm within the subgingival pocket (1). It is this 
inflammatory reaction caused by the host innate immune response to the bacterial 
pathogen that dictates the severity and progression of the periondontal infection (5). 
The oral biofilm consists of several hundred bacterial species, but periodontal 
disease is often associated with a progressive succession of the predominant bacterial 
species in dental plaque from Gram-positive to Gram-negative (1,4). In order for bacteria 
to colonize and persist in a host, bacterial pathogens must be able to counteract the innate 
and adaptive immune system of the host. Bacteria are able to evade the host immune 
system by maintaining a plethora of virulence factors. Many bacteria produce numerous 
virulence factors that have been well-characterized, including adherence proteins, 
cytotoxic factors, biofilm polysaccharides, chemotactic inhibitor, collagenases, LPS, and 
toxins to counteract the host immune system. It is these different bacterial behaviors and 
the resulting immune response to these pathogens that combine to promote inflammatory 
tissue destruction in periodontitis (5). The production by various proinflammatory 
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cytokines (i.e. IL-1B, IL-6, TNFu, IL-8, and RANKL) in response to specific Gram-
negative bacteria within the oral cavity leads to the activation of osteoclasts (37). 
Activation of the bone-resorbing osteoclasts eventually results in bone resorption and 
alveolar bone loss-clinical symptoms of periodontitis (41, 45, 51). 
Microbial Induction of Periodontal Disease 
Dental plaque is the single most important risk factor associated with the onset 
and progression of periodontal disease (1). The formation of dental plaque begins with 
adsorption of early colonizing bacteria onto an acquired pellicle, a layer of salivary 
proteins that is mainly composed of glycoproteins that forms shortly after a dental 
cleaning or tooth eruption. Once an acquired pellicle is formed, early colonizers are able 
to manipulate the environment in order for other bacteria to be able to colonize and 
adhere, thus forming dental plaque. It is this dental plaque that initiates the host 
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Figure 1. Anatomy of the periodontium (as reviewed by Baker, P.J. (12)). 
A) In health, gingival fibers connect the gingival soft tissue to the root of the 
tooth, and the alveolar bone and cementum are connected by periodontal ligament 
fibers. B) In periodontal disease, subgingival infection by Gram-negative bacteria 
results in soft tissue damage, producing attachment loss and deepening the sulcus 
into the periodontal pocket. Alveolar bone resorption moves the bone surface 
away from the tooth root (vertical bone loss) and reduces the height of the alveolar 
bone crest (horizontal bone loss). Copyright permission to reproduce figure 
granted by Elsevier and (5). 
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As mentioned previously, bacteria are able to adhere to the acquired pellicle on 
hard tissue to form a biofilm. The ability of bacteria to adhere tightly to underlying 
substrata impedes the efficient removal of biofilms by physical or chemical means. In the 
oral cavity, biofilms form on the surfaces of both hard and soft tissues, and the 
development of the biofilm depends on interactions between both bacterial cell-surface 
adhesions and host receptors and bacteria-bacteria interactions (12). Without the ability to 
adhere to surfaces in the oral cavity, bacteria are swallowed with the saliva and enter the 
digestive tract, where they may not survive. 
The last stage of bacterial colonization in the oral cavity involves late colonizers, 
whose presence is often associated with periodontal disease progression. A hallmark of 
inflammatory periodontal disease is the increased subgingival colonization by several 
Gram-negative species, including A. actinomycetemcomitans, Prevotella intermedia, 
Campylobacter rectus, and a group of three other bacteria designated 'the red complex' 
bacteria (T. den ticola , T. forsynthia, and P. gingivalis) (40). It is the bacteria previously 
mentioned that are considered the late colonizers or the anaerobic bacteria that cause this 
inflammatory reaction in the gingival tissues. The red complex is a group of 
microorganisms that are most intimately associated with adult periodontal disease. A. 
actinomycetemcomitans, another late colonizer, is associated with an aggressive form of 
periodontitis primarily found in juveniles, however this bacterial speices can also be 
found in chronic periodontitis as well (58). 
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Aggregatibacter actinomycetemcomitans 
A. actinomycetemcomitans (formerly Actinobacillus actinomycetemcomitans) is a 
small, fastidious, CO2-requiring coccobacillus (34). It is a capnophilic, facultative 
anaerobic Gram-negative bacterium that belongs to the family Pasteurellaceae (34). A. 
actinomycetemcomitans was initially isolated from actinomycotic oral lesions along with 
Actinomyces israelii, leading to its species name (30). A. actinomycetemcomitans was 
first isolated in 1912 (38), however it was never recognized as a member of the oral 
microbial environment until 1975 (35). A. actinomycetemcomitans has been associated 
with several systemic infections including chronic periodontitis, but the pathogen is most 
known for its strong association with localized aggressive periodontitis, an extremely 
destructive form of periodontal disease that is most common in adolescents and young 
adults (58). The fact that A. actinomycetemcomitans has also been recovered from 
subgingival microflora of periodontally healthy patients suggest that A. 
actinomycetemcomitans may also represent an opportunistic pathogen. Due to A. 
actinomycetemcomitans strong association with localized aggressive periodontitis, most 
studies of A. actinomycetemcomitans have focused on its role in this disease. If the 
disease is left untreated, localized aggressive periodontitis results in rapid destruction of 
the alveolar bone and all supporting structures ultimately causing tooth loss. The disease 
specifically targets the mandibular incisors and first molars (65). 
A. actinomycetemcomitans, like other bacterial pathogens, utilizes a plethora of 
virulence factors to cause disease and evade the host immune response. A. 
actinomycetemcomitans produces numerous virulence factors that have been well-
characterized, including adherence proteins, cytotoxic factors, biofilm polysaccharides, 
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chemotactic inhibitor, collagenases, LPS, and toxins. There is also strong evidence that 
leukotoxin (LtxA), a 116-kDa protein that belongs to the repeats-in-toxin (RTX) family 
of pore forming toxins, expression affects disease progression (8, 31). Studies have 
shown that the target of LtxA is quite specific, which is unusual among RTX toxins, 
killing only polymorphonuclear leukocytes, monocytes and T -cells, all cells responsible 
for the innate immune response, in humans, apes, and Old World monkeys (60). Previous 
studies have also demonstrated the ability of A. actinomycetemcomitans to bind and 
invade epithelial (43) and endothelial cells (56), which may be an important mechanism 
for evading the host immune system and disseminating beyond the initial site of infection 
(17). Furthermore, fresh clinical isolates of A. actinomycetemcomitans express fimbriae 
(Figure 2), which allow them to form tenacious biofilms on a variety of solid surfaces, 
such as hydroxyapatite, glass, and plastic (53). Fimbriae expression may be important in 
biofilm pathogenesis in vivo, however it is not the sole determinant in biofilm formation, 
as isogenic smooth strains are capable of forming biofilms (57). However fimbriae are 
thought to enable A. actinomycetemcomitans to colonize the tooth surface, persist in the 
oral cavity, and initiate infection in the presence of salivary flow, thus classifying them as 
a virulence factor. 
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Figure 2. Characteristics of clinical isolates of A. actinomycetemcomitans 
(16). A) When A. actinomycetemcomitans is initially isolated from the oral 
cavity and cultured on solid medium, it grows as a 'rough' colony with a 
characteristic star-like structure in the center. B) As the bacterium is 
passaged in liquid broth, it loses its ability to express fimbriae due to a 
spontaneous mutation in the flp promoter region, and the broth becomes 
turbid with the growth of isogenic non-adherent variants. When plated on 
solid medium, these variants form large, smooth colonies (16). Copyright 
permission to reproduce figure granted by Society for General Microbiology 
and (16). 
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Necessity of Iron 
Iron is the most abundant metal in nature, and as such, plays a major role in the 
life processes of all organisms (62). Iron is the central atom of the heme group in 
hemoglobin, which is necessary for oxygen transport in blood. Iron is also present in 
myogloboin which allows oxygen to diffuse through muscle cell), cytochromes (proteins 
involved in the electron transport chain), proteins involved with DNA synthesis and cell 
divison. Furthermore, iron is used to help produce the connective tissues in the human 
body, it is incorporated in the production of neurotransmitters, as well as playing an 
integral role in the maintenance of human immune system. Due to the fact that iron plays 
such a integral role in life processes it is tightly regulated. Too little iron can lead to iron 
deficiency anemia and present with symptoms of constant fatigue, palor, and severe 
weakness. Too much iron is known as hemochromatosis and can present as abdominal 
pain, fatigue, and generalized darkening of the skin. 
The paucity of free iron in mucous membranes, tissues, or body fluids acts as a 
host defense mechanism against bacterial infections by creating a bacteriostatic 
environment, because iron IS an essential nutrient for all life (22). Host iron binding 
proteins such as transferrin, lactoferrin, hemoglobin, ferritin all act collectively to 
maintain a low free iron concentration, thus inhibiting bacterial growth (63). As 
mentioned before all organisms require iron to survive. A critical component of bacterial 
virulence is the ability to obtain iron from their host. Several bacteria have evolved iron-
sequestering mechanisms such as the secretion of siderophores, which compete with host 
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Iron binding molecules for Iron. Previous research has shown that A. 
actinomycetemcomitans is not capable of binding transferrin (22, 64). In addition, this 
dental pathogen is not known to excrete siderophores (64). However, it has been shown 
that A. actinomycetemcomitans is capable of binding both lactoferrin and hemoglobin (2, 
21), two iron-containing compounds that serve as iron sources for other bacteria (48). 
The exact sources that A. actinomycetemcomitans utilizes in the oral cavity are not 
known. 
Research to date has shown that A. actinomycetemcomitans has at least 15 iron 
aquistion genes encoded in its genome (54). The amount of A. actinomycetemcomitans' 
genome involved in iron aquistion suggests the importance of iron availability to the 
survival of this organism. With all of this capability that A. actinomycetemcomitans has 
to obtain iron, there must be some discression or priority in the specific type of iron that 
A. actinomycetemcomitans prefers to utilize. The iron acquisition systems encoded in the 
genome of A. actinomycetemcomitans are tailored towards the specific survival strategies 
needed to survive in the oral biofilm. Due to A. actinomycetemcomitans genome and the 
the fact that A. actinomycetemcomitans IS a faculatative anaerobe, A. 
actinomycetemcomitans is expected to be able to utilize inorganic and organic as well as 
ferric and ferrous iron sources both in planktonic culture and biofilms. The most common 
iron transport systems utilized by bacteria seem to be the ferric iron transport complexes 
such as ABC transporters. However other bacteria such as H.. pylori, E coli, P. ginigivalis 
and V. cholera also employ ferrous iron transport through Feo (Ferrous Iron Transport) 
systems. Due to relatively soluble nature of ferrous iron (0.1 M for Fe2+ cf 10/\-18 M 
for Fe3+ at pH 7), it would seem that ferrous iron would be the preferred iron source for 
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most bacteria (68). However only under anaerobic conditions, or low pH environments 
does ferrous iron transport seem predominant. This fact lead us to believe that A. 
actinomycetemcomitans is able utilize ferrous iron as well as ferric iron transport in the 
oral cavity (68, 69, 70). Our hypothesis is that A. actinomycetemcomitans primarily 
utilizes ferric iron and hemin as iron sources in the oral biofilm due to the nature of A. 
actinomycetemcomitans genome. In this study, we investigate the planktonic growth of A. 
actinomycetemcomitans in an iron-limited and iron-chelated environment as well as 
analyze the ability of A. actinomycetemcomitans to grow in an iron-chelated environment 
supplemented with different iron sources and investigate what particular iron aquistion 
genes are being upregulated in each particular iron environment. 
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Gene Name GenelD Definition 
AAOO490,O 
hmsHf 0491 hemin transport and storage 
AA00696-0 
afuABC 0700 iron(llI) ABC transporter 
hgpA AAOO762 hemoglobin binding protein A 
AA00795-0 
fecBCDE 0799 iron(llI) dicitrate transporter 
hltABC AA01048-0 
(afuABC) 1051 iron (III) ABC transporter 
AA01642-0 
afuABC 1645 iron(llI) ABC transporter 
AA01824-0 
fatBDCE 1827 enterocheli n tra nsporter 
AA02120,O 
ftnAB 2121 nonheme ferritin 
AA02144,O 
hemU, fecD 2145 iron(lII) ABC transporter 
AA02151-0 
sidABCD 2154 ferric enterobactin transporter 
tbpA AA02201 transferrin-bind ing protein 
ferric hydroxamate (chelatin) periplasmic-binding 
fecS AA02380 protein 
fur AA02516 Fur, ferric uptake regulator 
AA02549-0 
AfeABCD 2552 iron (chelated) ABC transporter 
hasR AA02782 Outer membrane hemophore receptor 
Table 1. Iron Uptake Operons in A. actinomycetemcomitans. Iron acquisition operons 
encoded in A. actinomycetemcomitans genome (54). There is a redundancy of ferric iron 
transporters (ABC transporters), hemin and hemoglobin transporters. A. 
actinomycetemcomitans even seems to be able to utilize sideophore like molecules 
secreted from other bacteria through utilization of it's enterochelin transport system. 
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CHAPTER TWO: 
MATERIALS AND METHODS 
Bacterial strains and culture conditions. A. actinomycetemcomitans bacterial 
strain employed in this study was A. actiomycetemcomitans 652. A. 
actinomycetemcomitans 652 is an afimbriated, smooth colony morphotype strain and was 
grown at 3rC under microaerophilic conditions in Chemically Defined Media (CDM; 
Sigma-Aldrich, St. Louis, MO) and CDM supplemented with 150 uM of dipyridyl (DIP; 
Sigma-Aldrich, St. Louis, MO) per liter. Ferric Chloride, Ferric Citrate, Ferrous Sulfate, 
Hemin (Sigma-Aldrich, St. Louis, MO) were added to CDM with DIP at a 250 uM 
concentration per liter. 
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Table 2. Primers* used in this study. 
Primers Primer Sequence (5' - 3') Target Gene Size (kbp) 
5'00696 CGGATTACTCGCCTCACAAGCG afuA 00696 0.318 
3' 0696 CCTTTGGTTTTTGCCGGATCGC afuA 00696 0.318 
5' 00795 GCGCAGAAAATCGGTGATGTCGTGG fecB 00795 0.317 
0\ 
3' 00795 GCGATACTTTCCTGACGATAGTGTGC fecB 00795 0.317 
5' 5S rRNA GCGGGGATCCTGGCGGTGACCTACT 5S-2-rRNA 0.089 
3' 5S rRNA GCGATCTAGACCACCTGAAACCATACC 5S-2-rRNA 0.089 
5' 01642 CGCAGGCGGATTTTTGGTATGGCG afuA 01642 0.191 
3' 01642 CCGGCAGTTGAACCTCGCCTTTGTA afuA 01642 0.191 
5' AA02120 GCAAGGTTATGAAGGTGCTGCGGC ftnA/rsgA 02120 0.351 
3' AA02120 GCAGTGCCGCTTTTGCCAAGAAGTTTA ftnAlrsgA 02120 0.351 
5' AA00762 CCATGGAATTGAGACAACAAGCAACGTTAG hgpA AA00762 0.263 
3' AA00762 TCTAGATAGTCCAATTCCTGCGGTAAA hgpA AA00762 0.263 
Achievement of an Iron Limited Environment. A. actinomycetemcomitans was 
grown in a chemically defined media (CDM) in order to regulate the amount and type of 
iron that the bacteria could use for growth. A. actinomycetemcomitans was grown in 
CDM that contained FeS04 (CDM regular), and was then passaged into CDM that lacked 
an iron source (FeS04), creating an iron limited environment. 
Chemically Defined Media (COM) 
Amino Acids lL of 20x (g) 
L-Glutamic Acid HCI 27.2 mM 
Glycine 26.6 mM 
L-Threonine 16.79 mM 
L-Serine 19.03 mM 
L-Lysine HCI 10.95 mM 
L-Arginine HCI 11.49 mM 
L-Histidine HCI H2O 14.09 mM 
L-Glutamine 8.38 mM 
L-Asparagine H2O 15.12 mM 
L-Proline 13.23 mM 
L-Asparatic Acid 15.03 mM 
L-Ornithine HCI 2.37 mM 
L-H ydoxyproline 3.05 mM 
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Amino acids (Hydrophobic) lL of 20x (g) 
L-Alanine 22.45 mM 
D-Alanine 22.45 mM 
L-Leuicine 15.25 mM 
L-Valine 17.07 mM 
L-Tryptophan 9.79 mM 
L-Methionine 13.40 mM 
L-Isoleucine 15.25 mM 
L-Phenylalanine 12.11 mM 
L-Tyrosine 2.21 mM 
L- Cystine 416.2 ~M 
PurineslPyrimidines lL of 20x (g) 
Adenine 1.85 mM 
Guanine 1.32 mM 
Cytosine HCl 2.43 mM 
Thymine 1.59 mM 
Xanthine 1.31 mM 
Hypoxanthine 1.47 mM 
Uracil 1.78 mM 
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Inorganic Salts 1L of 20x (g) 
MnS04 830.8 11M 
NaCI 34.2 mM 
K2HP04 22.9mM 
KH2P04 146.9 mM 
KN03 19.78 mM 
Inorganic Salts lL of 20X (g) 
KI 12.05 11M 
CuS045H20 5.206 11M 
Boric Acid 161.7 11M 
ZnS047H20 56.8 11M 
Sodium 48.6 11M 
molybdate 
VitaminslFactors 1L of 1000x (g) 
Choline chloride 358.1 mM 
Beta-alanine 112.2 mM 
Pyridoxal 4.04mM 
Pyridoxine HCI 5.91 mM 











p- Aminobenzoic acid 
Vitamin B12 
NaHC03 




















lL of IX (g) 
FeS047H20 17.9 mM 
lL of Ix (mg) 
CaC122H20 680.2 11M 
lL of Ix 
Pimelic acid 624.2 nM 
0- Biotin 409.3 nM 
DL-6,8-thioctic 484.6 nM 
Folic acid 2.265 11M 
lL of IX (mg) 
Riboflavin 2.66 11M 
Table 6. A. actinomycetemcomitans Chemically Defined Media. All chemicals used 
were from Sigma-Aldrich, St. Louis, MO. 
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Achievement of an Iron Chelatt~d Environment. A. 
Actinomycetemcomitans growth was achieved by passaging the bacteria in an iron limited 
environment (a media in which no exogenous iron source was added) and an iron 
chelated environment (a media in which a chelator was added). On Day 1, A. 
actinomycetemcomitans strain 652 was inoculated into regular CDM from a frozen stock. 
This culture was incubated at 37°C overnight under microaerophilic conditions. On Day 
2, the bacteria from the overnight culture of regular CDM was inoculated into CDM with 
no iron plus 100 uM, 150 uM or 200 uM of dipyridyl (DIP) to achieve a 1 st passage in an 
iron chelated environment. This 1 st passage was incubated at 37°C overnight under 
microaerophilic conditions. On Day 3, the bacteria from the overnight culture of CDM no 
iron 1 st passage plus 100 uM, 150 uM, or 200 uM of DIP was inoculated into fresh media 
of CDM no iron plus 100 uM, 150 uM, or 200 uM of DIP to achieve a 2nd passage in an 
iron chelated environment. CDM no iron is an iron-limited environment. CDM no iron 
supplemented with DIP (iron chelator) is an iron-chelated environment. Growth of A. 
actinomycetemcomitans was accessed by measuring optical densities of the bacteria at 
















Figure 3: Achievement of an iron limited and iron chelated environment. 
Diagram shows how A. actinomycetemcomitans was passaged in order to achieve an iron 
limited environment. The same mechanism was utilized in order to obtain an iron 
chelated environment except in an iron chelated environment an iron chelator, dypridyl 
(DIP) , was added to the CDM No Iron at 100 uM, 150 uM, and 200 uM concentrations 
respectively. 
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RNA Isolation. Overnight cultures of the appropriate A. actinomycetemcomitans 
incubated at 37°C until the mid-exponential growth phase (O.D. of .08 for lSI passage 
CDM No Iron with 150 uM DIP and .028 for 2nd passage CDM No Iron with 150 uM 
DIP) for RNA isolation. Total RNA was isolated from A. actinomycetemcomitans cells 
using the 5 Prime PerfectPure RNA Cell & Tissue kit (5 Prime Inc., Gaithersburg, MD) 
according to the manufacturer's instructions. To ensure that the samples were free of 
contaminating genomic DNA, the RNA preparation was digested with RQ RNase-free 
DNase I (Promega Corporation, Madison, WI). The concentration and purity of each 
RNA sample were measured via spectrophotometry (ND-lOOO Spectrophotometer, 
NanoDrop Technologies, Inc, Wilmington, DE) and was also assessed by gel 
electrophoresis. Samples were checked for contamination of genomic DNA by real-time 
PCR using A. actinomycetemcomitans 5s rRNA primers (Table 2) RNA samples were 
considered free of significant genomic DNA if no amplification product was detected by 
real-time PCR after at least 30 cycles of amplification. RNA that was not immediately 
utilized for a reverse-transcription reaction was aliquoted into 1.5 ml Eppendorf tubes 
and stored at -80DC until future use. 
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cDNA synthesis and qPCR for iron acquisition gene expression. First-strand 
cDNA was prepared by using SuperScript III Reverse Transcriptase (Invitrogen, 
Carlsbad, CA) according to the manufacturer's instructions. Quantitative PCR (qPCR) 
was performed with the Smart Cycler system (Cepheid, Sunnyvale, CA) in a final 
reaction volume of 25 III that contained 100 ng of cDNA, appropriate iron acquisition 
primers (5' Induction and 3' Induction; -71 !AM final concentration), and Ix FastStart 
SYBER Green Master (Roche, Indianapolis, IN). The amplification conditions for qPCRs 
were as follows: denaturation at 95°C for 15 seconds, annealing at 55°C for 30 seconds, 
and elongation at 72°C for 30 seconds for 35 cycles. The threshold cycle for each qPCR 
was determined from a second derivative plot of total fluorescence as a function of cycle 
number by using the software package supplied with the Smart Cycler system. All gene-
specific threshold values were normalized against threshold values from primers specific 
for the A. aetinomyeetemeomitans 5S rRNA gene (-60 !AM final concentration). qPCR 
reactions were carried out in triplicate with consistent results. Each qPCR end-point 
amplification product was visualized by electrophoresis on 2% agarose gels. Primers 
utilized in this study included aJuA 1642 (iron III ABC transporter), aJuA 0696 
(periplasmic iron-compund binding protein), hgpA 0696 (hemoglobin binding protein A), 
JeeR 0795 (iron III dicitrate-binding protein), andJtnA 2120 (nonheme ferritin) (54). 
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CHAPTER THREE: EXPRESSION OF IRON ACQUISTION GENES 
Introduction: 
Dental plaque forms on surfaces of teeth and is composed of a dynamic micriobial 
community. As this microbial community matures, there is an increase in gram negative 
bacteria and decrease in gram positive bacteria. As gram negative bacteria proliferate in 
the oral biofilm, the host immune system reacts to the microbes, and eventually leads to 
periodontal disease. A. actinomycetemcomitans, is a gram negative coccibacillus, that is 
associated with the aggressive forms of periodontal disease. However in order for 
bacteria such as A. actinomycetemcomitans, to proliferate inside a human a host, iron is 
needed. Iron is an essential element needed for growth and normal metabolic functions in 
all organisms. Because the human host regulates iron, thus keeping a bacteriostatic 
environment, bacteria must overcome this iron sequesteration by encoding in its genome 
iron acquisition systems, in order to obtain iron from the host environment so that the 
bacteria may thrive and proliferate. Research to date has shown that A. 
actinomycetemcomitans has at least 15 iron aquistion genes encoded in its genome. The 
iron acquisition systems encoded in the genome of A. actinomycetemcomitans are tailored 
towards the specific survival strategies needed to survive in the oral biofilm. Due to all of 
the capability that A. actinomycetemcomitans has to obtain iron, there must be some 
dicression or priority in what type of iron A. actinomycetemcomitans prefers to utilize for 
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growth. Due to the redundancy of ferric iron transporters in A. actinomycetemcomitans 
geneome and the major iron sources that A. actinomycetemcomitans will encounter to in 
the oral cavity lead us to our hypothesis that A. actinomycetemcomitans primarily utilizes 
ferric iron, obtained from iron chelators or host proteins, and hemic as iron sources in the 
oral cavity. 
Results: 
A. actinomycetemcomitans is capable of growing in an iron-limited 
environment. In order for us to test A. actinomycetemcomitans' ability to grow in an 
environment that lacked an iron source, A. actinomycetemcomitans was first grown in an 
iron rich media (CDM regular) overnight in an incubator at 37C. One millliliter of 
overnight planktonic cultures of A. actinomycetemcomitans strain 652 grown in CDM 
regular was inoculated into fresh CDM 19 mL. Growth was analyzed for 12 hours by 
measuring the Optical Density at 600 nm every hour. The first passage with no iron 
culture was achieved by inoculating from an overnight culture of A. 
actinomycetemcomitans grown in CDM regular into fresh CDM with no added iron 
source (CDM No Iron). The second passage CDM No Iron culture was achieved by 
inoculating from an overnight culture of A. actinomycetemcomitans grown in the first 
passage of CDM No Iron. The third passage CDM No Iron culture was achieved by 
inoculating from an overnight culture of A. actinomycetemcomitans grown in the second 






Growth curve of 652 in COM Regular and 1 st, 2nd, and 3rd Passage No 
Iron COM 
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Figure 4. Growth of A. actinomycetemcomitans in an iron-limited 
environment. Growth of A. actinomycetemcomitans measured by spectrometery O.D. 
600 nm. Growth was measured in triplicates, results of growth were averages ± standard 
deviations. 
Results showed that A. actinomycetemcomitans was able to grow in an lion 
limited environment. Growth occurred similarily 10 all 3 passages of A. 
actinomycetemcomitans without an iron source. These results lead us to a couple of 
conclusions, either A. actinomycetemcomitans was capable of growing very well in an 
iron limited environment due to large internal iron storage system that lasted the bacteria 
well into the third passage or there were trace amounts of iron in media CDM No Iron, 
even though no exogenous iron source was added to the media. This lead us to to our 
second experiement of obtaining an iron-chelated environment. 
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An iron-chelated environment reduces the growth of A. 
actinomycetemcomitans. Passages in an iron chelated environment were achieved as 
described above in Figure 4. However, the growth of A. actinomycetemcomitans was 
analyzed in an iron-chelated enivornment at different concentrations of dypyridyl (DIP). 
Growth was analyzed for 12 hours by measuring the Optical Density at 600 nm every 
hour, as above. Figure 5a. DIP was added to the 151 and 2nd passages at 100 ~M. Figure 
5b. DIP was added to the 151 and 2nd passages at 150~M. and Figure 5c. DIP was added to 




















Overlay of 652 Growth in Regular CDM and 
1st and 2nd Passages In No Iron CDM with 
100 uM DIP 
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Figure Sa. Achievement of an Iron Chelated Environment with 100 uM DIP. 
Growth of A. actinomycetemcomitans measured by spectrometery O.D. 600 nm. Growth 





















Overlay of 652 Growth in Regular CDM and 1 st and 2nd 
Passages in No Iron CDM with 150 uM DIP 
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Figure 5b. Achievement of an Iron Chelated Environment with 150 uM DIP. 
Growth of A. actinomycetemcomitans measured by spectrometery O.D. 600 nm. Growth 
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Figure Sc. Achievement of an Iron Chelated Environment with 200 oM DIP. 
Growth of A. actinomycetemcomitans measured by spectrometery O.D. 600 nm. Growth 
was measured in triplicates, results of growth were averages ± standard deviations. 
Results from these growth analyses displayed that an iron-chelated environment 
reduces the growth of A. actinomycetemcomitans. It also proved that A. 
actinomycetemcomitans has an internal iron storage system that allows growth in an iron 
chelated environment well into the 151 passage. However by the 2nd passage of A. 
actinomycetemcomitans in an iron chelated environment the internal iron storage system 
had been depleted and A. actinomycetemcomitans growth was drastically reduced. It also 
proved that there were trace elements of iron in the No Iron CDM media that A. 
actinomycetemcomitans was able to utilize for growth. Now that an environment was 
created in which A. actinomycetemcomitans was depleted of all sources, we then decided 
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to add different sources of iron in order to see what types of iron that A. 
actinomycetemcomitans preferred to utilize for growth. 
Growth of A. actinomycetemcomitans utilizing different iron sources. To 
determine A. actinomycetemcomitans ' ability to utilize iron sources for growth, the l SI 
passage CDM No Iron with 150 !!M DIP was inoculated into fresh CDM No Iron with 
150 !!M DIP medium supplemented with 250 !!M of hemin , ferric chloride, ferric citrate, 
or ferrous sulfate. To prevent ferrous sulfate from oxidizing to ferric sulfate, the growth 
was analyzed under anaerobic conditions. The 1 SI passage was achieved as in Figure 3. 
Growth was analyzed for 12 hours by measuring the Optical Density at 600 nm every 
hour. Results are averages of O.D. at 600 nm ± standard deviations. 
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0.7 
Overlay of 652 Growth in Regular COM and 1st Passage with No Iron with 150 uM with DIP 
and 2nd Passages in Iron Supplemented Environments 
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0.5 +--------------------7-'-----
~ O .4~--------------~-------- r~~-lst-pa-SS-ag-e -15-0-UM-D-IP---, 
c: 
1l! 
o -6- Ferric Citrate 250 uM with ISO uM DIP 
o 0 .3+----------~~-------~~=---
0 .2 ~-------_+"_---__=',c:;.-""7"''_= __ =------
0 .1 +----------1h ;,ol!=--x-+".-f'------=_""""---""'--
o 5 10 15 20 25 
.......... FerrousSulfate 250 uM with 150 uM 
DIP 
~ Ferric Chloride 250 uM with 150 uM 
DIP 
__ Hemin 250 uM with 150 uM DIP 
Figure 6. Growth of A. actinomycetemcomitans utilizing different iron sources 
with 150 uM DIP and 250 uM of appropriate iron sources. Growth of A. 
actinomycetemcomitans measured by spectrometery O.D. 600 run. Growth was measured 
in triplicates, results of growth were averages ± standard deviations . 
Hemin, Ferric Chloride, and Ferric Citrate are iron sources that A. 
actinomycetemcomitns is capable of utilizing for growth. Growth of A. 
actinomycetemcomitans in ferrous sulfate was similar to the amount of growth that was 
witnessed in the 2nd passage in an iron chelated environment leading us to the the 
conclusion that A. actinomycetemcomitans appears to not to be able to utilize ferrous 
sulfate as effectively for growth. Now that A. actinomycetemcomitans growth was 
analyzed under different iron conditions, we wanted to see what particular iron genes 
were up regulated or down regulated during these various iron conditons. 
34 
Expression of iron-uptake genes under an iron-chelated environment. 
Cultures utilized in this experiment were achieved as described in Figure 2. RNA was 
extracted mid exponential phase (O.D. of .08 for the first passage in CDM no iron and 
O.D. of .025 for the second passage in CDM no iron). RNA was isolated and cDNA was 
synthesized as described in the previous methods. Real-time PCR was performed using 
primers specific for iron genes. Iron genes utilized in this study were chosen based on the 
genes association with qorum sensing, due to the fact that previous research has shown 
that iron acquisition in A. actinomycetemcomitans is regulated by qorum sensing (72). 
Expression of genes are normalized to 1st passage expression. Results are averages of 
Delta T ± standard deviations. Delta T was calculated by subtracting the cycle threshold 
(Ct) determined for the each particular iron gene reaction from the Ct of the 5s rRNA 
control. 
Table 4a. afuA 1642 (iron (III) ABC transporter 
delta T delta (delta T) Fold Change 
2nd Passage in 9.52 ± 1.008 0.0013 ± 0.8 E-3 0.134 ± 3.350 
CDM No Iron with 
150 uM DiP 
1 st Passage in CDM 6.63 ± 0.001 0.010 ± 0.7 E-3 1 
No Iron with 150 
uMDIP 
delta T was calculated by subtracting the cycle threshold (Ct) determined for the afuA 
01642 reaction from the Ct of the 5s rRNA control. P value = 0.031 
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Table 4b. afuA 0696 (periplasmic iron-compound-binding protein) 
delta T delta (delta T) Fold Change 
2nd Passage in 13.68 ± 0.601 7.62E-5 ± 0.03 E-3 9.52 ± .081 
CDM No Iron with 
150 uM DIP 
1 st Passage in CDM 15.87 ± 0.467 8 E-6 ± 0.002 E-3 1 
No Iron with 150 
uMDIP 
delta T was calculated by subtracting the cycle threshold (Ct) determined for the afuA 
0696 reaction from the Ct of the 5s rRNA control. P value = 0.0150 
Table 4c. hgpA 0762 (hemoglobin binding protein A) 
delta T delta (delta T) Fold Change 
2na Passage in 9.133 ± 1.100 0.002 ± .001 .319 ± .241 
CDM No Iron with 
150 uM DIP 
1 st Passage in CDM 7.486 ± 0.962 0.006 ± .004 1 
No Iron with 150 
uMDIP 
delta T was calculated by subtracting the cycle threshold (Ct) determined for the hgpA 
0762 reaction from the Ct of the 5s rRNA control. P value = 0.0978 
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Table 4d. feeB 0795 (iron(III) dicitrate-binding protein 
delta T delta (delta T) Fold Change 
20d Passage in 2.06 ± .064 0.240 ± .011 2.02 ± .007 
CDM No Iron with 
150uMDIP 
1 st Passage in CDM 3.076 ± 0.050 0.119 ± .004 1 
No Iron with 150 
uMDIP 
delta T was calculated by subtracting the cycle threshold (Ct) determined for the feeB 
0795 reaction from the Ct of the 5s rRNA control. P value = 0.0003 
Table 4e. ftnA 2120 (nonheme ferritin) 
delta T delta (delta T) Fold Change 
20d Passage in 8.009 ± .003 0.004 ± 0.004 E-3 .809 ± 0.286 
CDM No Iron with 
150 uM DIP 
1 st Passage in CDM 7.704 ± .424 0.005 ± .001 1 
No Iron with 150 
uMDIP 
delta T was calculated by subtracting the cycle threshold (Ct) determined for the feeB 
0795 reaction from the Ct of the 5s rRNA control. P value = 0.0816 
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Discussion: 
Target genes utilized in this study were chosen due to the fact that previous 
research has shown that iron acquisition in A. actinomycetemcomitans are regulated by 
qorum sensing (58). The target genes in this study were associated with quorum sensing. 
Results showed that in an iron chelated environment, iron uptake genes of A. 
actinomycetemcomitans are differentially regulated. Using the 1 sl passage as a starting 
point presented as a potential limitation. CDM regular, media containing an iron source, 
should have been baseline and as we started to starve the bacteria we could have 
witnessed differential regulation in gene expression. Real time PCR results were 
normalized to the lSI. AfuA 1642, an iron III ABC transporter, was ultimately turned 
down during the second passage in CDM No Iron with 150 uM DIP. AfuA 0696 showed 
an up regulation of the gene during the 2nd passage in CDM No Iron with 150 uM DIP. 
This was a very interesting result. AfuA 1642 showed down regulation during the 2nd 
passage and AfuA 0696 showed an up regulation during the 2nd passage. This suggest that 
there may be some distinction between these two ferric iron transporters. It may be 
possible that under very limiting iron conditions that A. actinomycetemcomitans is 
upregulating ferric iron transport that may be specific for iron coming from a particular 
source and the other ABC transporter may be down regulated because it is intended to 
transport iron obtained from a different source .. While cells are starving, there seems to 
be an upregulation of afuA 0696 andfecB 0795, an iron (III) ABC transporter, and a iron 
(III) dicitrate binding protein (scavenging system) respectively. The gene regulation of 
ftnA 2120 essentially stayed the same in the first and the second passage. This makes 
sense thatftnA 2120 is not being regulated at all considering it is essentially an iron 
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storage molecule. There was down regulation of the hemoglobin binding protein, hgpA 
0762 and afuA 0696. What is interesting is that there are three different afuA annotated 
gene clusters in A. actinomycetemcomitans, and all three have different sequences. This 
may suggest that these genes may differentially expressed, may have different functions, 
and may be expressed under different conditions. 
Due to the fact that A. actinomycetemcomitans possess a wide variety of potential 
mechanisms to obtain iron sources, of the iron acquisition genes encoded in A. 
actinomycetemcomitans genome, A. actinomycetemcomitans differentially expresses 
genes according to what environment it is in and what different iron sources it is exposed 
to. 
39 
CHAPTER FOUR: SUMMARY AND FUTURE DIRECTIONS 
Iron is the most abundant metal in nature, and as such plays a major role in many 
life processes of all organisms. In the human host, iron is highly regulated, creating a 
bacteriostatic environment. However in order for organisms to survive they must be able 
to overcome this iron limitation by encoding in their genome iron aquisition systems. 
Research to date has revealed that A. actinomycetemcomitans has encoded in its genome 
at least 15 iron aquisition systems to overcome this bacteriostatic environment (67). The 
iron acquisition systems enoded in A. actinomycetemcomitans are tailored towards the 
specific survival strategies needed to survive in the oral biofilm. Thus A. 
actinomycetemcomitans is expected to be able to utilize inorganic and organic as well as 
ferric and ferrous iron sources both in planktonic culture and biofilms. These particular 
findings were expected due to the redundancy of ferric iron transporters in A. 
actinomycetemcomitans genome, and the particular Iron sources that A. 
actinomycetemcomitans encounters in the oral cavity. In this study, we investigated the 
planktonic growth of A. actinomycetemcomtians in an iron-limited and iron-chelated 
environment as well as analyze the ability of A. actinomycetemcomitans to grow in an 
iron-chelated environment supplemented with different iron sources and investigate what 
particular iron aquistion genes are being upregulated in an iron chelated environment. 
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We discovered that A. actinomycetemcomtians is capable of growing in an iron 
limited environment, that though there wasn't a external iron source added to the media 
that A. actinomycetemcomitans was able to scavage trace amounts of iron from other 
chemicals III the CDM, and efficiently use it for growth. However A. 
actinomycetemcomitans was not capable of growing in an iron chelated environment. By 
the second passage in an iron chelated environment A. actinomycetemcomitans growth 
was drastically reduced. This lead us to the conclusion that A. actinomycetemcomitans 
has an excellent internal iron storage system that the bacteria is capable of using for 
growth during the first passage of growth but is not large enough to use for growth during 
the second passage. The reduction of growth of the bacteria in an iron-chelated 
environment occurred in a dose dependent manner. 
Growth of A. actinomycetemcomitans utilizing 250 uM of ferric citrate, ferric 
chloride, and hemin respectively with 150 uM DIP restored growth to the levels above 
the 1 sl passage in an iron chelated environment. Growth of A. actinomycetemcomitans 
was higher in an hemin iron environment, suggesting that A. actinomycetemcomitans 
prefers hemin as an iron source. However A. actinomycetemcomitans growth in a ferrous 
sulfate iron source was very low. It was very similar to the amount of growth that was 
witnessed in the 2nd passage in an iron-chelated environment leading us to the conclusion 
that A. actinomycetemcomitans appears to not to be able to utilize ferrous sulfate as 
effectively for growth. This was not suprising considering the analysis of A. 
actinomycetemcomitans genome did not reveal in iron acquisition genes for ferrous iron 
sources. However we thought that because A actinomycetemcomitans is an anaerobic 
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bacteria, that in an anerobic environment that A. actinomycetemcomitans may be able to 
utilize the non oxidized ferrous iron source. 
Results from Realtime PCR showed that in an iron chelated environment, iron 
uptake genes of A. actinomycetemcomitans are differentially regulated. Using the 1 st 
passage as a starting point presented as a potential limitation. CDM regular, media 
containing an iron source, should have been baseline and as we started to starve the 
bacteria we could have witnessed differential regulation in gene expression. Real time 
PCR results were normalized to the 2nd passage and what was seen was afuA 1642 
showed a 7 fold increase than in the 1 st passage compared to the 2nd passage. AfuA 0696 
showed a 10 fold higher increase than in the 2nd passage that in the 1 st passage. While 
cells are starving, there seems to be an upregulation of afuA 0696 and fecB 0795, and 
iron (III) ABC transporter, and a iron (III) dicitrate binding protein (scavenging system) 
respectively. The gene regulation offtnA2120 essentially stayed the same in the first and 
the second passage. This makes sense that ftnA2120 is not being regulated at all 
considering it is essentially and iron storage molecule. There was a down regulation of 
the hemoglobin binding protein and afuABC 0696. What is interesting is that there are 
three different afuA annotated gene clusters in A. actinomycetemcomitans, and all three 
have different sequences. This may suggests that these genes may differentially expressed 
may have different functions, and may be expressed under different conditions. 
Though many questions have had some light shed on them during my research, 
more research still needs to be done. Ultimately the original idea of my research was to 
first look at the expression of a couple of these iron acquisition systems under the initial 
iron conditions used, in other words the 1st and 2nd passages in CDM No Iron with 150 
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uM DIP. After the expression of the iron acquisition genes were established under the 
iron chelated conditions, our goal then was to add back specific iron sources and see what 
happened to gene expression with the different iron operons under these different iron 
conditions. The first part of our goal we accomplished, however the second part is a 
project that a future student will carryon. I also only focused on a limited numbers of 
operons, in the future more iron acquisition genes should be included. Also to make my 
research show more validity, mutant strains of A. actinomycetemcomitans should be 
formulated, knocking out specific iron operons and testing the growth and gene 
regulation under the different iron conditions. Because past and current research all 
describe A. actinomycetemcomitans as growing in a biofilm, more studies on iron 
aqusition genes with A. actinomycetemcomitans grown in a biofilm formation are needed 
if there are any hopes in formulating a chelator that is strong enough to chelate the 
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